Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Preferred Stock Liabilities: 2013-2014

  • Ocular Therapeutix's Preferred Stock Liabilities was N/A to $74.4 million in Q2 2014 from the same period last year, while for Jun 2014 it was $74.4 million, marking a year-over-year change of. This contributed to the annual value of $74.3 million for FY2013, which is N/A change from last year.
  • Ocular Therapeutix's Preferred Stock Liabilities amounted to $74.4 million in Q2 2014, which was up 0.01% from $74.3 million recorded in Q4 2013.
  • Ocular Therapeutix's Preferred Stock Liabilities' 5-year high stood at $74.4 million during Q2 2014, with a 5-year trough of $74.3 million in Q4 2013.
  • In the last 2 years, Ocular Therapeutix's Preferred Stock Liabilities had a median value of $74.3 million in 2013 and averaged $74.3 million.